Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Fundam Clin Pharmacol ; 11(3): 221-30, 1997.
Article in English | MEDLINE | ID: mdl-9243253

ABSTRACT

The increased sympathetic drive in chronic heart failure (CHF) might provoke vascular adrenoceptor desensitization, which, together with endothelial dysfunction, could contribute to the altered vasomotor tone seen in CHF. We investigated 1) whether CHF alters the responses mediated by alpha and beta adrenoceptors in small and large peripheral arteries, and 2) the effect of angiotensin-converting enzyme (ACE) inhibition. Rats with CHF (coronary artery ligation) were treated with placebo or the ACE inhibitor lisinopril (10 mg/kg/d) starting 7 days after ligation. Responses to phenylephrine (alpha 1 agonist), salbutamol (beta 2 agonist) as well as acetylcholine (endothelium-dependent), were assessed after 3 months in isolated and pressurized segments of the abdominal aorta, the femoral and the mesenteric arteries. In animals with hemodynamic signs of CHF, neither the vasoconstrictor responses to phenylephrine nor the vasodilator response to salbutamol were affected. In contrast, the dilator response to acetylcholine of both small arteries, but not that of the aorta, was impaired. Furthermore, CHF did not modify vessel structure. While lisinopril did not modify the responses to adrenergic agonists, it normalized the response to acetylcholine. Furthermore, ACE inhibition reduced vascular media cross sectional area and collagen density. Thus, the unchanged arterial responsiveness to adrenoceptor agonists does not indicate any vascular adrenoceptor desensitization, while endothelial dependent vasodilation of small arteries is impaired in CHF. ACE inhibition does not modify the response to adrenergic stimuli, prevents endothelial dysfunction and induces both cardiac and vascular remodeling, which probably contribute to the effect ACE inhibitors have on exercise tolerance and survival.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Endothelium, Vascular/physiopathology , Heart Failure/physiopathology , Lisinopril/pharmacology , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Acetylcholine/pharmacology , Adrenergic alpha-Agonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Albuterol/pharmacology , Animals , Aorta, Abdominal/drug effects , Aorta, Abdominal/pathology , Aorta, Abdominal/physiopathology , Chronic Disease , Endothelium, Vascular/drug effects , Endothelium, Vascular/pathology , Femoral Artery/drug effects , Femoral Artery/pathology , Femoral Artery/physiopathology , Heart Failure/pathology , Hemodynamics/drug effects , In Vitro Techniques , Male , Mesenteric Arteries/drug effects , Mesenteric Arteries/pathology , Mesenteric Arteries/physiopathology , Muscle Contraction/drug effects , Muscle Relaxation/drug effects , Neurotransmitter Agents/blood , Nitroprusside/pharmacology , Phenylephrine/pharmacology , Rats , Rats, Wistar , Renin-Angiotensin System/drug effects
2.
Am J Physiol ; 271(2 Pt 2): H469-77, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8770086

ABSTRACT

Chronic heart failure (CHF) induces peripheral vasoconstriction and impairs endothelium-dependent relaxation of large arteries. We investigated in a rat model of CHF (coronary artery ligation) 1) whether endothelial dysfunction also exists in resistance arteries, 2) whether this is associated with vascular morphological changes, and 3) the effect of angiotensin-converting enzyme (ACE) inhibition on these parameters. After 1 mo or 1 yr, CHF reduced the vasodilatory response to acetylcholine of isolated, perfused femoral and mesenteric artery segments. This impairment was more marked in femoral than in mesenteric arteries. However, CHF did not induce any arterial remodeling. Chronic treatment with the ACE inhibitor perindopril improved the response to acetylcholine and reduced media cross-sectional area and collagen density. Thus at the level of small peripheral arteries, CHF induces an endothelial dysfunction but does not affect vascular structure. ACE inhibition prevents the CHF-induced endothelial dysfunction and induces vascular remodeling. These changes could contribute to the observed beneficial effects of ACE inhibitors on hemodynamics and survival in CHF.


Subject(s)
Cardiac Output, Low/physiopathology , Endothelium, Vascular/physiopathology , Femoral Artery/pathology , Femoral Artery/physiopathology , Acetylcholine/pharmacology , Angiotensin I/pharmacology , Angiotensin II/pharmacology , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Cardiac Output, Low/pathology , Endothelium, Vascular/drug effects , Femoral Artery/drug effects , Hemodynamics/drug effects , In Vitro Techniques , Indoles/pharmacology , Male , Myocardial Infarction/mortality , Myocardial Infarction/pathology , Nitroprusside/pharmacology , Perindopril , Rats , Rats, Wistar , Vasodilator Agents/pharmacology
3.
Am J Hypertens ; 8(5 Pt 2): 7S-12S, 1995 May.
Article in English | MEDLINE | ID: mdl-7646844

ABSTRACT

Chronic heart failure (CHF) impairs endothelium-dependent vasodilatation of large conductance arteries. We investigated whether a similar reduction also occurs in small arteries, and whether such a reduction can be prevented by the angiotensin converting enzyme inhibitor perindopril (P) in a rat model of CHF (left coronary artery ligation). After 1 month treatment with placebo or P (2 mg/kg/day), rats were anesthetized and arterial pressure, left ventricular end-diastolic pressure, and central venous pressure were measured with a micromanometer. Segments of aorta and mesenteric artery (mean diameter, 281 +/- 8 microns) were then isolated, cannulated, and perfused at constant pressure using an arteriograph. Responses to increasing concentrations of acetylcholine (Ach), nitroprusside, and to 10(-4) mol/L NG-nitro-L-arginine methyl ester (L-NAME) were studied after preconstriction by phenylephrine. Heart failure resulted in a decrease in systolic and diastolic pressures, an increase in left ventricular end-diastolic and central venous pressures, and a significant depression of Ach-induced dilatation of the mesenteric artery (maximal dilatation, from 90 +/- 4% to 63 +/- 4%, P < .05) but not of the aorta (from 56 +/- 8% to 45 +/- 5%, NS) without any modification in the endothelium-independent vasodilatation induced by nitroprusside. In the group treated by the angiotensin converting enzyme (ACE) inhibitor perindopril, systolic and diastolic pressures were slightly decreased, whereas left ventricular end diastolic, central venous pressures, and the endothelium-dependent vasodilating response to Ach were normalized. Responses to L-NAME were not affected by CHF or perindopril. Perindopril also decreased hypertrophy, as evidenced by a significantly lower heart weight in treated rats.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/pharmacology , Endothelium, Vascular/drug effects , Heart Failure/prevention & control , Indoles/pharmacology , Vasodilation/drug effects , Animals , Aorta/drug effects , Chronic Disease , Disease Models, Animal , Heart Failure/physiopathology , Hemodynamics/drug effects , Male , Mesenteric Arteries/drug effects , Muscle, Smooth, Vascular/drug effects , Perindopril , Random Allocation , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...